A Real-world, Multicenter, Retrospective, Cohort study to evaluate the effectiveness of Glecaprevir and pibrentasvir in Japanese patients with chronic hepatitis C genotype 1 or 2 infection
Latest Information Update: 19 Jul 2019
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 19 Jul 2019 New trial record
- 01 Jun 2019 Results published in the Hepatology Research